Full text is available at the source.
Abstract
The effectiveness and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were assessed in adults with weight recurrence after metabolic and bariatric surgery.
- GLP-1 RAs may provide a therapeutic option for adults experiencing weight regain following metabolic and bariatric surgery.
- The assessment focused on both the effectiveness and safety of GLP-1 RAs in this specific population.
- Findings could inform future treatment strategies for managing weight recurrence after surgical interventions.
Simplified